Pediatric Clinical Research Center

A hypothesis by Rutgers Health researchers suggests a common stimulant could protect infants from sudden death.

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease.